/Lists

Biotech Growth Investors & VC Firms

708 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.

Foresite Capital
West HollywoodSeed–Late Stage
44 people
SoftBank Group
TokyoSeries B–Growth
23 people
Future Planet Capital
LondonSeed–Growth
31 people
Triton Partners
LondonSeed–Growth
105 people
Wellington Management
BostonGrowth–Late Stage$5M – $50M
84 people
Sixth Street
San FranciscoGrowth–Late Stage$50M – $2.5B
78 people
Longitude Capital
Menlo ParkSeries A–Late Stage$10M – $30M
61 people
Bayern Kapital
LandshutSeed–Late Stage$275K – $55M
46 people
WCAS
New YorkGrowth
91 people
Oxford Science Enterprises
OxfordPre-Seed–Growth$63.5K – $31.8M
71 people
Paladin Capital Group
WashingtonSeed–Growth$100K – $5M
65 people
Vivo Capital
Palo AltoSeed–Late Stage$10M – $50M
58 people
IMM Investment Japan
TokyoSeed–Growth
21 people
Nippon Venture Capital
TokyoPre-Seed–Growth$300K – $5M
29 people
NVIDIA
Santa ClaraPre-Seed–Growth
17 people
TPG
San FranciscoGrowth–Late Stage
70 people
YFM Equity Partners
LeedsGrowth$3.9M – $19.5M
64 people
HOF Capital
New YorkPre-Seed–Growth$500K – $10M
45 people
Dementia Discovery Fund
LondonSeed–Late Stage
81 people
Birch Hill Equity Partners Management Inc.
TorontoGrowth–Late Stage$75M – $3B
74 people
Blackstone Life Sciences
New YorkSeries A–Late Stage$20M – $60M
82 people
Obvious Ventures
San FranciscoPre-Seed–Late Stage$250K – $6M
40 people
Sky9 Capital
San FranciscoPre-Seed–Growth$1M – $10M
48 people
Innovestor Ventures
HelsinkiSeed–Growth$270K – $3.2M
28 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.